Nomura Adjusts Sirnaomics' Price Target to HK$67.07 From HK$70.07, Keeps at Buy
Nomura Adjusts Sirnaomics' Price Target to HK$70.07 From HK$107.14, Keeps at Buy
UBS Adjusts Alphamab Oncology's Price Target to HK$12.94 From HK$13.22, Keeps at Buy
UBS Adjusts CARsgen Therapeutics' Price Target to HK$34.50 From HK$38, Keeps at Buy